Interaction of cerebrovascular disease and contralateral carotid occlusion in prediction of shunt insertion during carotid endarterectomy by Estruch-Pérez, María J. et al.
Interaction of cerebrovascular disease and contralateral








1, María M. Morales-Suarez-Varela
3
Abstract
Introduction: To assess the possible role and the interaction of cerebrovascular
disease and vascular stenosis on the necessity of shunt insertion during carotid
endarterectomy (CEA).
Material and methods: Eighty consecutive patients undergoing CEA under region-
al anaesthesia were prospectively enrolled. Patients were divided into two groups
depending on whether they were shunted or not. The measured end-points
were co-morbidities degree of contralateral and carotid stenosis and other intra-
and postoperative outstanding parameters. ANOVA, Student’s t and χ2 tests
were used (p < 0.05). Variables differing significantly between groups and poten-
tial confounders were used in backward stepwise logistic regression to estimate
the relative risk (RR, 95% CI) of shunt. In addition Wald’s test (p < 0.05) with
and without adjustments for potential confounders was used with various dif-
ferent multivariate analysis models. 
Results: Contralateral stenosis and cerebral vascular accidents (CVA) were more
frequently observed in shunted patients. The RR for patients with contralater-
al stenosis ≥ 50% was 1.3 (95% CI 1.0-1.5) and for patients with previous CVA
was 1.2 (95% CI 1.0-1.4). For contralateral stenosis and CVA together the RR
increased to 7.7 (95% CI 1.0-14.4). A model based on contralateral stenosis and
CVA was found to be statistically significant (p = 0.003) for shunt (RR = 1.1,
95% CI 1.0-2.1). Relative excess risk due to interaction of both factors was 6.2.
Conclusions: The findings suggest that patients with contralateral stenosis 
≥ 50% and previous CVA have a higher risk of requiring shunt use during CEA
than patients with these risk factors separately.
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Introduction
Carotid endarterectomy (CEA) has become a well-established technique
to prevent the risk of stroke in symptomatic and asymptomatic patients,
as reviewed in recent trials [1, 2]. However, the long-term benefit must out-
weigh the perioperative risk (stroke and death). Most perioperative strokes
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are ischaemic and some are caused by low blood
flow during the carotid clamping period. The inser-
tion of an intraluminal shunt to minimize the risk
of low flow and intraoperative stroke has been
used. A recent Cochrane Review [3] of routine ver-
sus selective carotid artery shunting showed that
the currently available data were too limited to sup-
port or refute the use of routine or selective carotid
shunting in patients undergoing CEA under gener-
al anaesthesia. However, the use of a shunt makes
the operation technically more demanding and car-
ries potential complications such as embolism or
damage to arterial walls. Shunt insertion has also
been related to postoperative internal carotid artery
(ICA) re-stenosis after CEA [4] and to subclinical
neurocognitive dysfunction [5], although the liter-
ature also shows controversy. In this context, it
would be an advantage to preoperatively predict
which patient will need a shunt. Neuromonitoring
methods easy to apply, such as bispectral index,
have been investigated for monitoring of cerebral
ischaemia to allow selective shunt insertion [6]. 
Factors such as moderate ipsilateral carotid
stenosis, degree of contralateral stenosis or pre-
operative symptoms of cerebrovascular disease
[7-15] have been associated with shunt placement
due to cerebral ischaemia during CEA. These reports
suggest shunting patients with the factors men-
tioned with poor strength of association that could
improve with the combination of factors. With
awake patients under regional anaesthesia it was
possible for us to use a selective shunt while mon-
itoring neurological status during surgery. With this
approach, we undertook an observational prospec-
tive study to identify preoperative or intraoperative
characteristics of the patients associated with neu-
rological changes consistent with cerebral ischaemia
which needed shunting. In particular, we assess the
possible role and the interaction of cerebrovascu-
lar disease and vascular stenosis on the necessity
of shunt insertion during CEA.
Material and methods
This prospective observational single-centre
study was conducted in the vascular surgery
department at Dr Peset Hospital, Valencia, Spain,
from November 2005 to December 2007. The pro-
tocol was approved by the local ethics committee,
which waived the requirement for informed con-
sent as data were collected while care of patients
conformed to standard procedures currently used
in our institution. During a three-year period, all
patients undergoing CEA [1, 2] were operated on
under a regional anaesthesia protocol and they
were invited to participate in the study. Patients
allergic to regional anaesthetics, who refused
regional anaesthesia, with cognitive limitation, anx-
iety, orthopnoea, a known language barrier or ASA
V were excluded from the protocol. Based on these
criteria, 80 patients were included and, of these,
only one was converted to general anaesthesia.
Perioperative management was standardized. For
the preoperative selection of study patients the main
tool used for extracranial screening, diagnosis and
follow-up was Echo-Doppler testing in accordance
with the consensus conference of the Society of
Radiologists in ultrasound [16]. Other studies such
as arteriography or magnetic resonance angiogra-
phy were only used if doubts were found with echo-
Doppler testing about the stenosis percentage [1]. 
Standard instrumentation was used in the oper-
ating room: all patients were monitored using five-
lead ECG, pulse oximetry, and invasive measure-
ment of mean arterial pressure (MAP). An 18G
intravenous cannula was placed in the forearm and
intravenous premedication, either 1-2 mg of mida-
zolam (MDZ) or 1 mg MDZ and 50 μg of fentanyl,
was given 10 minutes before placing a cervical
plexus block to provide anxiolysis, as deemed nec-
essary by the anaesthetist. During the procedure,
each patient received oxygen at 3 l/min via nasal
prongs. For regional anaesthesia, 20 ml of bupiva-
caine 0.375% was administered for the deep cervi-
cal plexus block following a modified version of the
single-injection technique proposed by Winnie 
et al. [17] or using a three-injection technique at C2,
C3 and C4 as described by Moore [18]. Mepivacaine
2% (20 ml) was administered for the superficial cer-
vical plexus block at the midpoint of the posterior
border of the sternocleidomastoid muscle. If the
patient noted pain during surgery, the surgeon
administered supplementary 1% lidocaine directly
around the carotid sheath. Also, 0.10 mg of fentanyl
was used in cases when additional sedation or pain
relief was required in the course of the surgery. The
MAP was maintained using vasodilators or volume
expanders and catecholamines to maintain systolic
blood pressure within the normal limits (±20% of
basal blood pressure values).
Carotid stenosis consists of removal of plaque
through the open common carotid by means of
a pre-jugular approach. Clamping of the internal and
external carotid is necessary. Heparin (5000 U i.v.)
was given before carotid cross-clamping. A clamp-
ing test was performed for 3 min to determine tol-
erance to low cerebral flow through the carotid
artery. Cerebral ischaemia during clamping was
assumed when neurological changes were detect-
ed and a Javid shunt was placed from the common
carotid artery to the intact internal carotid artery.
The carotid was closed directly or by means of
a path. Heparin was reversed with protamine after
surgery in some patients at the discretion of the
surgeon. The patient was kept in the ICU for the
first 24 h to allow close monitoring of blood pres-
sure, neurological condition and drainage. Pre- and
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postoperative routine antiplatelet drug therapies
(acetylsalicylic acid, clopidogrel) were not withheld
and were given according to pre-existing prescrip-
tions. In all patients the CEA was performed using
the same method and by the same surgical team.
Patients continued to take their routine medication
until the morning of surgery.
Data collection
For each patient, the following data were col-
lected: preoperative risk factors for morbidity and
mortality (patient characteristics, smoking habit,
main identified comorbidities); previous symptoms
(cerebral vascular accident – CVA, transient
ischaemic accident – TIA); American Society of
Anesthesiology (ASA) classification, and preopera-
tive medication; intra-postoperative data (degree
of ipsilateral stenosis and contralateral carotid
stenosis, duration of surgery and clamping, ICU and
hospital stay, postoperative blood pressure, intra-
postoperative antihypertensive therapy); and 
30-day postoperative complications (death, neuro-
logical signs and symptoms (CVA, TIA), acute
myocardial infarction (AMI), and other complica-
tions such as cranial nerve deficits and surgical
haematoma). These data were prospectively
entered into a database for later analysis.
Relevant previous symptoms were considered to
be CVA or TIA, including amaurosis fugax as
a symptom of carotid stenosis. Patients were con-
sidered to be asymptomatic if the aforementioned
pathologies and the carotid stenosis had been
detected following a full vascular assessment in the
context of another vascular disease or as an inci-
dental observation made during an examination for
another non-vascular disease. 
Cerebral ischaemia during clamping was assumed
when neurological changes were detected. Specifi-
cally, the neurological changes considered to indi-
cate cerebral ischaemia were as follows: focal neu-
rological deficits (tested by requesting the patient to
move each of their limbs and squeeze a toy);
decreased consciousness [19], tested by assessing
speech using the verbal component of the Glasgow
Coma Scale; and dysarthria [19]. The period of carotid
clamping used to record neurological changes dur-
ing neurological monitoring was a 3-min clamping
test. The need for Javid shunt placement was based
on the occurrence of neurological changes during
this 3-min clamping test and whether neurological
deficits required conversion from regional to gener-
al anaesthesia prior to shunt insertion. 
Statistical analysis
For data analysis, we divided a posteriori the 
80 individuals into two groups according to shunt
insertion during surgery: shunted patients (n = 12)
and non-shunted patients (n = 68). 
Quantitative results are presented as means and
standard deviations (SD), minimum and maximum,
while qualitative results are reported as absolute
and relative (percentages) frequencies. 
Statistical analysis was performed in two steps.
The first step was a descriptive analysis with two-
way repeated measures ANOVA for continuous vari-
ables and the χ2 test for proportions to compare dif-
ferences between shunted and non-shunted groups;
p-values less than 0.05 were considered statistical-
ly significant. In the second step, the associations of
patient characteristics with shunt insertion were
analysed using relative risk (RR, 95% CI), after which
we ran various models adjusted by RR (95% CI)
including variables found to be significant in the first
step. Statistical analysis was also performed using
forward stepwise logistic regression (cut-off value of
p = 0.05; Wald test) with the use of a shunt as the
dependent variable, and the following as independ-
ent variables: high blood pressure (HBP); percent-
ages of occlusion in ipsilateral disease and, sepa-
rately, in contralateral disease; CVA; TIA; and
asymptomatic status. Potential associations between
preoperative and intraoperative variables and shunt
were first tested by univariate analysis. We also cal-
culated the relative excess risk due to interaction of
the risk factors identified in the study [20].
Statistical calculations were performed using SPSS
statistical software, v.15 (SPSS, Chicago, IL, USA).
Results
The cohort investigated (n = 80) comprised 
71 men (88.75%) and 9 women (11.25%), who ranged
from 45 to 82 years old (mean age: 66.06 ±9.07
years; mean weight: 72.24 ±9.32 kg). The mean
degree of stenosis was 85.2 ±8.7%, with a minimum
and maximum stenosis of 70% and 99%.
Previous symptoms were TIA including amauro-
sis fugax (n = 21) and CVA that included reversible
ischaemic neurological deficits (RINDs) (n = 41) or
both (n = 2). In 62 symptomatic patients (77.5%)
the degree of carotid stenosis was 86.7 ±8.6% and
in the 18 asymptomatic patients (22.5%) it was 80.5
±7.6%, with a p value = 0.019. 
The demographic data and medical history of
shunted and non-shunted patients are given in
Table I. Shunted patients had significantly higher
levels of contralateral stenosis and they had a high-
er frequency of previous symptoms (described
before) although this was not significant. 
In 15 patients (18.5%) clinical cerebral ischaemia
was diagnosed by mental confusion, agitation, rest-
lessness and/or contralateral upper limb motor
deficit. In 11 of these patients (11/15, 73.3%) the
deficit occurred at the time of the 3-min clamping
test and it was reversed after shunt insertion. Over-
all, a shunt was needed in 12 patients (15.0%), 
11 around the time of clamping when the deficit
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Parameter Shunt Value of p*
Shunted patients Non-shunted patients
(n = 12) (n = 68)
Age [years] Mean ±SD 64.4 ±7.9 66.4 ±9.1 0.49
Min-max 50-76 45-82
≤ 65 8 (66.7%) 28 (41.2%) 0.11
65-74 3 (25.0%) 25 (36.8%) 0.65
≥ 75 1 (8.3%) 15 (22.1%) 0.48
Gender Male  11 (91.7%) 60 (88.2%) 0.88
Female 1 (8.3%) 8 (11.8%)
ASA II 0 (0.0%) 8 (11.9%)
III 9 (75.0%) 49 (73.1%) 0.80
IV 3 (25.0%) 10 (14.9%) 0.64
Surgical carotid Left 8 (66.7%) 37 (56.1%) 0.49
Right 4 (33.3%) 29 (43.9%)
Degree of stenosis [%]             Mean 84.0 +10.1 85.4 ±8.5 0.60
70-90% 5 (41.7%) 33 (50.0%) 0.51
> 90% 7 (58.3%) 33 (50.0%) 0.59
Contralateral stenosis [%] Mean 66.7 ±33.7 31.3 ±33.1 0.04*
≤ 50% 2 (16.7%) 38 (55.9%) 0.01*
50-70% 5 (41.7%) 19 (27.9%) 0.54
≥ 70% 5 (41.7%) 11 (16.2%) 0.10
With previous symptoms: 62/80 (77.5%)
TIA 1 (8.3%) 22 (32.4%) 0.18
CVA  9 (75.0%) 32 (47.1%) 0.07
Asymptomatics: 18/80 (22.5%)    2 (16.7%) 16 (23.5%) 0.88
HBP 56 (70.0%) 10 (83.3%) 46 (68.9%) 0.51
Controlled HBP 9 (75.0%) 39 (84.8%) 0.64
BP at admission Mean ±SD
Min-max   
Systolic BP    142.2 ±18.4 141.2 ±15.9 0.85
130-180 100-170
Diastolic BP 74.5 ±7.8 75.3 ±11.2 0.82
80-55 90-50
IHD 4 (33.3%) 13 (21.0%) 0.55
AMI treatment 3 (75.0%) 9 (69.2%) 0.95
IHD progression in years Mean ±SD 6.9 ±3.1 4.6 ±5.0 0.15
Min-max 4-13 1-18
Non-ischaemic heart disease  0 6 (9.0%)
Peripheral artery disease  6/12 (50.0%) 30/68 (44.1%)  0.71
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appeared. In just 1 patient (1/15, 6.6%) the deficit
occurred before clamping with restlessness and agi-
tation [19] and anaesthesia was switched over to
general prior to insertion of the shunt. The other
three patients (3/15, 20%) presented neurological
deficits after the clamping period. None of these
shunted patients reported permanent neurological
deficits on discharge from hospital.
Table II shows perioperative data and postop-
erative complications stratified according to
whether or not patients had a shunt placed. There
were no statistical differences between patients.
Regarding neurological complications, two (2.5%)
of the non-shunted patients had CVAs after sur-
gery while 1 patient suffered permanent deficit due
to surgical carotid occlusion. Two non-shunted
patients died 30 days after surgery: one from an
intracranial haemorrhage, in the context of
a hyperaemic response, and one from a ruptured
aneurysm, while another non-shunted patient suf-
fered from angina pectoris in the postoperative
period. Eighteen patients (22.5%) suffered from
other complications including cervical haematoma
and cranial nerve paralysis, with no significant dif-
ferences. In none of these patients was discharge
delayed.
In Table III, the RRs of shunted patients are
shown, with respect to non-shunted patients. We
observed that contralateral stenosis ≥ 50% (RR: 1.3;
95% CI: 1.0-1.5) and previous symptoms of CVA 
(RR: 1.2; 95% CI: 1.0-1.4) were associated with shunt
insertion. With contralateral stenosis ≥ 50% and pre-
vious symptoms of CVA combined, the RR increased
to 7.7 (95% CI: 1.0-14.4). The calculated relative
excess risk due to interaction of contralateral steno-
sis ≥ 50% and previous symptoms of CVA was 6.2.
Discussion
The main finding of this study was the interac-
tion existing in patients with contralateral stenosis
≥ 50% associated with previous CVA, which has not
been previously reported. These patients have
a seven-fold greater tendency to require shunt
insertion in patients under regional anaesthesia.
Impaired ischaemic tolerance after previous strokes
has already been observed [7, 12-14]. In the pres-
ent study there was also a higher shunt frequency
in patients who had suffered a prior stroke (83.3%
vs. 76.6%), but this difference did not reach statis-
tical significance, probably due to the small sample
size. The shunt incidence in the group with a con-
tralateral ICA ≥ 50% was 83.4% vs. 43.%. Shunted
patients had a poorer health status than non-shunt-
ed patients in terms of pre-, intra- and postopera-
tive parameters. It is likely that shunted patients
did not have sufficient collateral cerebral circulation
or that they had more cerebral areas at risk of
ischaemia from changes in functional metabolism
[12, 21], so were more sensitive to any kind of cere-
bral hypoperfusion. The reported results could sup-
port the view that the presence of unilateral,
asymptomatic carotid stenosis is not associated
with an increased risk of stroke following cardiac
surgery if prophylactic CEA is not performed [22].
If we had followed the recommendation that
carotid surgery can be performed safely without
a shunt in patients with contralateral stenosis 
≤ 50% and without previous ACV, we would have
Parameter Shunt Value of p*
Shunted patients Non-shunted patients
(n = 12) (n = 68)
Antiplatelet drugs 62/80 (77,5%) 11 (91.7%) 51 (75.0%) 0.81
Aspirin 3 (25.0%) 17 (25.4%) 0.72
Clopidogrel 4 (33.0%) 24 (35.8%) 1
Aspirin + clopidogrel 4 (33.0%) 8 (11.9%) 0.14
Acenocoumarol 0 2 (3.0%)
Renal disease 0 9 (13.4%)
Dyslipidaemia 56 (70.0%) 11 (91.7%) 45 (67.2%) 0.18
Statin therapy 43/56 (76.8%) 9 (81.8%) 34 (75.6%) 0.72
Smoking habit 11 (91.6%) 53 (80.3%) 0.62
NIDDM/IDDM 15(18.8%)/10 (12.5%) 1 (8.3%)/1 (8.3%) 14 (20.9%)/9 (13.4%) 0.55/1
Table I. cont.
Data are mean ± standard deviation (SD) or number (%) and minimum and maximum (min-max). TIA – transient ischaemic accident, CVA – cere-
bral vascular accident, HBP – high blood pressure, BP – blood pressure, IHD – ischaemic heart disease, AMI – acute myocardial infarction, 
NIDDM – non-insulin-dependent diabetes mellitus, IDDM – insulin-dependent diabetes mellitus
*p value < 0.05,  χ2 and analysis of variance (ANOVA) tests
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put three patients at risk of developing major neu-
rological deficits. Overall contralateral stenosis 
≥ 50% and previous ACV wrongly predicted the
requirement for a shunt in 36.8% (25/68), roughly
a third of the patients. We found this a poor pre-
dictor relation with the awake neurological test.
Contrary to other reports where previous neu-
rological symptomatology and/or intraoperative
shunting were identified risk factors for increased
complications [23], in our study there was not an
increase of complications for patients with signifi-
cant preoperative variables (contralateral stenosis
≥ 50% and previous symptoms of CVA) or intraop-
erative shunt insertion and postoperative high
blood pressures were not significant. Recent reviews
have highlighted the importance of optimal med-
ical therapy with antiplatelet drugs and statins [24,
25]. Statins are effective in reducing both first-ever
and recurrent stroke [26] and antiplatelet drugs are
also very effective to avoid the platelet hyperag-
gregation state in CEA [27]. Statin effects may
improve collateral blood flow, enhance cerebral
Parameter Shunt Value of p*
Shunted patients Non-shunted patients
(n = 12) (n = 68)
Duration of surgery [min] Mean ±SD 126.4 ±39.8  108.3 ±21.9 0.24
Min-max 75-210 65-185
Duration of clamping [min]
Mean ±SD 50.8 ±15.6 43.9 ±16.5 0.18
Min-max 30-70 17-110
ICU [days] Mean ±SD  1.2 ±0.7 1.3 ±0.7 0.86
Min-max 1-3 1-4
Hospital stay Mean ±SD 3.7 ±2.1 3.6 ±1.1 0.95
Min-max 2-9 3-8
Complications
No complications 9 (75.0%) 48 (70.6%) 0.98
With complications 3 (25.0%) 20 (29.4%) 0.88
Neurological         0 2 (2.9%)
Postoperative AMI  0 1 (1.5%)
30 day death      0 2 (2.9%)
Other complications 3 (25.0%) 15 (22.1%) 0.88
Postoperative BP Mean ±SD     
Systolic BP 1 h 144.7 ±29.8 133.94 ±27.2 0.21
6 h 136.2 ±28.8 133.2 ±27.1 0.73
12 h 140.3 ±22.0 127.4 ±21.9 0.06
18 h 148.1 ±19.3 135.7 ±21.9 0.07
24 h 151.1 ±19.3 138.1 ±24.3 0.08
Diastolic BP 1 h 66.1 ±14.5 62.9 ±14.1 0.47
6 h 62.2 ±14.9 60.3 ±14.2 0.67
12 h 62.5 ±11.3 57.7 ±12.4 0.22
18 h 65.6 +10.3 60.6 v12.6 0.20
24 h 70.6 ±7.6 68.0 ±14.7 0.35
Intraoperative antihypertensive drugs 9/12 (75.0%) 38/68 (55.9%) 0.46
Postoperative antihypertensive drugs 6/11 (54.5%) 21/68 (30.9%) 0.13
Table II. Perioperative data and postoperative complications
Data are mean ± standard deviation (SD); BP – blood pressure, ICU – intensive care unit
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vasodilation during periods of compromised flow,
and prevent carotid thrombosis and embolism in
the perioperative period. Both antiplatelet drugs
and statins were used in 91.75% of shunted
patients and 75-67.2% respectively of the non-
shunted patients. The use of shunt and optimal
medical preventative therapies should be comple-
mentary: shunt insertion would be usefully sup-
ported by antiplatelet therapy, to avoid associated
thromboembolic complications, while the shunt
would help to prevent stroke by hypoperfusion.
Selective shunting has been related to postop-
erative cognitive dysfunction [4]. Better cognitive
outcomes have been observed following CEA under
regional anaesthesia [28] and, in addition, cardiac
and pulmonary morbidity associated with general
anaesthesia can be avoided. While this approach
involves more stress for the medical professionals
involved, it seems to offer significant benefits to
patients. The GALA study [29] compared general
versus regional anaesthesia in 3526 patients. In
relation to major complications of stroke, AMI or
death, there was no evidence for deciding whether
to use general or regional anaesthesia. However,
regional anaesthesia did decrease shunt insertion
(14% vs. 43%, p < 0.001). The need to increase blood
pressure was more common under general anaes-
thesia, while it was more often necessary to
decrease blood pressure when regional anaesthe-
sia was used. In other research, higher levels of
postoperative hypertension have been attributed
to pharmacological or surgical carotid sinus dener-
vation [30]. Our patients also mainly needed anti-
hypertensive drugs and this was most common in
shunted patients in the intraoperative and in the
postoperative period, especially 12 h post surgery
(Table II). Hypertension is the most important risk
factor for stroke [31] and reperfusion syndrome; for
this reason it is advisable to monitor these shunt-
ed patients in the ICU during the immediate post-
operative period. In the GALA study, rates of
reversible cranial nerve lesions, haematoma and
reintervention did not differ between the types of
anaesthesia, in spite of the lower rates of shunt use
in regional anaesthesia. In our study, there were
more of these complications in shunted patients,
which we attributed to the arterial surgical manip-
ulation, but the difference was not significant. 
The limitations of this study are that a relative-
ly low percentage of patients were shunted and had
serious complications, and that the sample size is
not sufficiently large to draw strong conclusions.
However, this study has a high level of internal
validity and homogeneity because it was carried
out under a strict protocol and by the same team,
preventing treatment protocol bias, which is not
the case in other studies involving hundreds of
patients from different hospitals and under differ-
ent protocols. 
Our findings suggest that patients with con-
tralateral occlusion ≥ 50% and with previous CVA
present greater risks of shunt use during CEA than
patients with these risk factors separately. The com-
bination of both contralateral occlusion ≥ 50% and
previous CVA become synergic and strengthen the
risk of shunt insertion. 
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